In recent years, the saturation of advertising in traditional media, and especially on the Internet, has led to so-called banner blindness: the ability of consumers not to see or record the advertisements they bombard day after day. An Infolinks study suggests that 86% of consumers have banner blindness, suggesting that only 14% of respondents remember the last ad they had seen, the brand and the product promoted. If you advise clients or patients to earn a living, you know that protecting sensitive and personal information is essential. But are you aware of what is considered a breach of trust or what to do if that happens? Daniele Archibugi and Andrea Filippetti argue that the importance of TRIPS in the process of developing and disseminating knowledge and innovation has been overestimated by its supporters. This was supported by the FINDINGs of the United Nations that many low-protection countries regularly benefit from significant foreign direct investment (FDI).  Analysis of OECD countries in the 1980s and 1990s (which extended the lifespan of drug patents by 6 years) showed that, although the total number of registered products increased slightly, the average innovation index remained unchanged.  On the other hand, J-rg Baten, Nicola Bianchi and Petra Moser (2017) find historical evidence that compulsory licensing – a key mechanism for weakening IP rights under Article 31 of TRIPS – can effectively lead to the promotion of inventions by increasing the threat to competition in areas of low competition. They argue, however, that the benefits of weakening intellectual property rights depend heavily on the ability of governments to make a credible commitment to use them only in exceptional cases, since companies can invest less in research and development if they expect repeated episodes of mandatory licensing. After more than 18 years of war in Afghanistan, the United States and the Taliban have agreed on the most intense efforts to date by both sides to end the war. The agreement focuses on the significant withdrawal of U.S. troops and the Taliban`s assurances that the country will not become a safe haven for terrorists. The TRIPS agreement contains certain provisions relating to known trademarks that complement the protection required by Article 6 bis bis of the Paris Convention, which was incorporated by reference to the TRIPS agreement and which requires members to refuse or cancel registration and prohibit the use of a trademark that conflicts with a known trademark.
First, the provisions of this section also apply to services. Second, it is necessary to take into account the knowledge acquired in the relevant field of the public, not only through the use of the mark, but also through other means, including as a result of its promotion. In addition, the protection of known trademarks must cover products or services that are not similar to those for which the trademark has been registered, provided that their use indicates a link between those products or services and the owner of the registered trademark and that the interests of the licensee could be affected by such use (Article 16.2 and 3). An agreement reached in 2003 relaxed domestic market requirements and allows developing countries to export to other countries with a public health problem as long as exported drugs are not part of a trade or industrial policy.  Drugs exported under such regulations may be packaged or coloured differently to prevent them from affecting the markets of industrialized countries.